Does CYTARABINE Cause White matter lesion? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of White matter lesion have been filed in association with CYTARABINE (cytarabine). This represents 0.1% of all adverse event reports for CYTARABINE.
57
Reports of White matter lesion with CYTARABINE
0.1%
of all CYTARABINE reports
0
Deaths
18
Hospitalizations
How Dangerous Is White matter lesion From CYTARABINE?
Of the 57 reports, 18 (31.6%) required hospitalization.
Is White matter lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause White matter lesion?
ADALIMUMAB (84)
METHOTREXATE (83)
FINGOLIMOD (71)
PREDNISONE (42)
METRONIDAZOLE (41)
LEVETIRACETAM (38)
RITUXIMAB (37)
AMPHOTERICIN B (34)
DAUNORUBICIN (33)
CEFUROXIME (30)
Which CYTARABINE Alternatives Have Lower White matter lesion Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB